修正案 发表于 2025-3-25 05:32:03

http://reply.papertrans.cn/1/92/9167/9167-21.png

最高峰 发表于 2025-3-25 10:12:52

http://reply.papertrans.cn/1/92/9167/9167-22.png

TEM 发表于 2025-3-25 15:41:16

http://reply.papertrans.cn/1/92/9167/9167-23.png

雄辩 发表于 2025-3-25 19:53:28

Submitted on: 16 August 2004.
Revised on: 09 December 2004.
Accepted on: 11 January 2005.

___________________European Journal of Hospital Pharmacy

承认 发表于 2025-3-25 21:00:35

Submitted on: 12 February 1998.
Revised on: 22 April 1998.
Accepted on: 06 May 1998.

___________________European Journal of Hospital Pharmacy

抚育 发表于 2025-3-26 00:09:54

http://reply.papertrans.cn/1/92/9167/9167-26.png

Vasoconstrictor 发表于 2025-3-26 04:17:30

http://reply.papertrans.cn/1/92/9167/9167-27.png

white-matter 发表于 2025-3-26 10:37:51

http://reply.papertrans.cn/1/92/9167/9167-28.png

HEW 发表于 2025-3-26 13:06:51

Submitted on: 04 January 2009.
Revised on: 16 April 2009.
Accepted on: 26 May 2009.

___________________European Journal of Hospital Pharmacy

Bone-Scan 发表于 2025-3-26 17:45:18

http://reply.papertrans.cn/1/92/9167/9167-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊European Journal of Hospital Pharmacy 2024/2025影响因子:1.669 (EUR J HOSP PHARM) (2047-9956). (PHARMACOLOGY & PHARMAC